aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19

NEXT STORY
Monthly information on share capital and company voting rights
PREV STORY
Adaptive Biotechnologies Reports First Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CytomX to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 02, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

author_avatar
NASDAQ Market News

Immutep Raises A$6.85m Through Institutional Placement

A$6.85m raised through share institutional placement to drive immuno-oncology development programsPlacement of new ordinary ...

author_avatar
NASDAQ Market News

Matrix Medical Network to Present at 2018 RISE Quality Leadership Summit

SCOTTSDALE, Ariz., June 22, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix), a leading ...

author_avatar
NASDAQ Market News